Related Experiment Videos
[Outcomes of the treatment of complicated stomach cancer]
Voenno-Meditsinskii Zhurnal
|February 1, 1983
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[The surgical procedure in acute calculous cholecystitis].
Voenno-meditsinskii zhurnal·1991
[Clinico-instrumental methods in the diagnosis and treatment of acute pancreatitis].
Vestnik khirurgii imeni I. I. Grekova·1988
[Diagnosis and treatment of benign nonepithelial tumors of the large intestine].
Voprosy onkologii·1980
1602nd Military clinical hospital celebrates the 75th anniversary.
Voenno-meditsinskii zhurnal·2019
Moscow hospital school - a pionner of military-medical education in Russia.
Voenno-meditsinskii zhurnal·2019
The chief of Medical department of Military ministry.
Voenno-meditsinskii zhurnal·2019
Medical Service of the Polish Armed Forces.
Voenno-meditsinskii zhurnal·2019
Organization of medical support of contingent in event of a sea accidents and disasters.
Voenno-meditsinskii zhurnal·2019
Professional reliability of military pilots: medical and social-psychological aspects.
Voenno-meditsinskii zhurnal·2019
Time to Treatment Failure as a Recorded Treatment-Process Measure in C-CAT. Reply to Comment on "Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462".
Current oncology (Toronto, Ont.)·2026
Does Time to Treatment Failure Measure the Same Clinical Process Across Oncology Facilities? Comment on Kajiura et al. Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462.
Current oncology (Toronto, Ont.)·2026
[177Lu]Lu-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer: Evidence from PSMAddition and Considerations for Treatment Sequencing.
Current oncology (Toronto, Ont.)·2026
A New Era of Treatment Sequencing in Platinum-Resistant Ovarian Cancer: Integrating Immunotherapy, Antibody-Drug Conjugates, and Targeted Therapies.
Current oncology (Toronto, Ont.)·2026